The measurement of the biomarker for diagnosis of th retinopathy of prematurity

The measurement of the biomarker for diagnosis of th retinopathy of prematurity - The biomaker of ROP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022720

Enrollment

100

Registered

2016-06-15

Start date

2015-11-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinopathy of prematurity

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pretern infants,less tha 31weeks postconceptional age, who are hospitalized in the neonatal intensive care unit at Tokyo Metropolitan Children's Medical center, Tokyo Metropolitan Bokutoh Hospital and Tokyo Metropolitan Ohtsuka Hospital are eligible for enrollment.Written informed consent was obtained from parent of each neonate.

Exclusion criteria

Exclusion criteria: 1.neonate with chromosomal anomaly 2.neonate with multiple malformation 3.neonate with ophthalmogic abnormality 4.neonate who is judged to be inappropriate as sublect.

Design outcomes

Primary

Measure	Time frame
We examine relations between tryptase level and onset of the retinopahy of prematurity.	—

Secondary

Measure	Time frame
1.We examine relations between tryptase level and gestational age and birth weight. 2.Postnatal change of the tryptase level. 3.We examine relations between tryptase level and severity of the retinopathy of prematurity.	—

Countries

Japan

Contacts

Public ContactMasatoshi Kondo

Tokyo Metropolitan children's Medical Center Department of Neonatology

masatoshi_kondou@tmhp.jp042-300-5111

Outcome results